8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2017 / Randomized, double-blind, crossover trial
In a randomized, double-blind, crossover study, 12 normoglycaemic overweight or obese men received rectal infusions of SCFA mixtures high in acetate (HA), propionate (HP), butyrate (HB), or placebo during fasting and postprandial conditions. All three SCFA mixtures increased fasting fat oxidation (P < 0.01), while resting energy expenditure increased following HA and HP compared to placebo (P < 0.05). Furthermore, all three SCFA mixtures increased fasting and postprandial plasma PYY concentrations and attenuated fasting free glycerol concentrations compared with placebo (P < 0.05).
Canfora EE, van der Beek CM, Jocken JWE, et al. Sci Rep, 2017. PMID 28539646
2017 / Randomized controlled trial
In a randomized trial, 166 patients receiving pelvic radiotherapy were assigned to low-fiber, habitual-fiber, or high-fiber dietary counseling. Although the primary endpoint of start-to-nadir bowel score changes did not differ significantly between groups (P = 0.093), high-fiber advice led to smaller score reductions from start to end of radiotherapy (-3.7 ± 12.8 vs -10.8 ± 13.5; P = 0.011). At 1 year, the high-fiber group maintained significantly better bowel scores than the habitual-fiber group (+0.1 ± 14.5 vs -8.4 ± 13.3; P = 0.004).
Wedlake L, Shaw C, McNair H, et al. Am J Clin Nutr, 2017. PMID 28679552
2017 / Prospective single-group trial
Biologic-naïve patients with Crohn disease received standard infliximab induction along with a lacto-ovo-semivegetarian diet during hospitalization. Two adults were withdrawn due to intestinal obstruction. Intention-to-treat and per-protocol remission rates at week 6 were 96% (44/46) and 100% (44/44), respectively. Mean CDAI score dropped from 314 on admission to 63 at week 6 (p < 0.0001), mean CRP decreased from 5.3 mg/dL to 0.2 mg/dL (p < 0.0001), and mucosal healing was achieved in 46% (19/41) of cases.
Chiba M, Tsuji T, Nakane K, et al. Perm J, 2017. PMID 29035182
2016 / Prospective comparative effectiveness trial
A prospective comparative effectiveness trial compared cow's milk elimination (n = 20) with swallowed fluticasone (n = 24) in newly diagnosed pediatric patients with eosinophilic esophagitis (EoE). After 6-8 weeks, peak esophageal eosinophil counts dropped below 15 eosinophils/high-power field in 64% of the cow's milk elimination group and 80% of the fluticasone group (P = 0.4). In the milk elimination group, mean PedsQL EoE Module total scores improved from 69 to 82 (P < 0.005) and Total Symptoms scores improved from 58 to 75 (P = 0.001). For swallowed fluticasone, scores also significantly improved (Module: 64 to 75, P < 0.05; Symptoms: 58 to 69, P < 0.01).
Kruszewski PG, Russo JM, Franciosi JP, et al. Dis Esophagus, 2016. PMID 25721813
2016 / Prospective single-group study
Researchers evaluated the effect of 'The Thinker' posture (bending the upper body) on defecation using cinedefecography in 22 patients unable to evacuate barium paste while normally seated. During straining, 'The Thinker' position resulted in a significantly wider ARA (134° vs. 113°, p = 0.03), larger PPD (9.3 vs. 7.1 cm, p = 0.02), and longer PRL (15.2 vs. 12.9 cm, p = 0.005) compared with the sitting position. Additionally, 11 of the 22 patients were able to evacuate completely in 'The Thinker' position.
Takano S, Sands DR Tech Coloproctol, 2016. PMID 26690926
2016 / Double-blinded randomized sham-controlled trial
In a double-blinded randomized sham-controlled trial, patients with Crohn's disease excluded for 4 weeks either four food types with the highest IgG4 antibody titers (true diet) or four with the lowest titers (sham diet). Milk, beef, pork, and egg were most commonly excluded in the true diet group. Out of 96 tested, 76 completed the study, showing a 3.05 (0.01-6.11) p < 0.05 improvement in SIBDQ and a 41 (10.4-71.5) p = 0.009 improvement in CDAI.
Gunasekeera V, Mendall MA, Chan D, et al. Dig Dis Sci, 2016. PMID 26809868
2016 / Multicenter randomized double-blind placebo-controlled crossover trial
Patients with functional gastrointestinal symptoms followed a 3-week gluten-free diet (GFD), and responsive patients were randomly assigned to 5.6 g/day gluten or placebo for 7 days followed by crossover. Of 134 patients completing the GFD, 101 reported symptomatic improvement (VAS 2.3 ± 1.2 vs. 6.5 ± 2.2, p = 0.001). Among 98 patients undergoing the challenge, 28 experienced symptomatic relapse and reduced quality of life during gluten intake; however, 14 also responded to placebo. Adjusting for the placebo response, approximately 14% of patients responding to gluten withdrawal had a symptomatic relapse during the gluten challenge.
Elli L, Tomba C, Branchi F, et al. Nutrients, 2016. PMID 26867199
2016 / Randomized crossover trial
In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.
Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559
2016 / Pilot nutritional intervention
In a pilot nutritional intervention, 25 healthy subjects (mean age 38.3) consumed 12 Nocellara del Belice green table olives daily for 30 days. Results showed a significant variation in malondialdehyde and a significant decrease in interleukin-6 levels. Additionally, a reduction of fat mass with an increase of muscle mass was observed, whereas no statistically significant differences were found in fecal Lactobacilli concentrations despite a trend toward an increase. The authors caution that these preliminary findings must be verified in a larger sample.
Accardi G, Aiello A, Gargano V, et al. Immun Ageing, 2016. PMID 27053940
2016 / Randomized crossover trial
Twenty healthy nonobese men completed an fMRI food picture evaluation task after consuming control inulin or inulin-propionate ester in a randomized crossover design. Increasing colonic propionate reduced the blood oxygen level-dependent signal in the caudate and nucleus accumbens, with the caudate reduction driven specifically by a decreased response to high-energy food. These effects were accompanied by lower subjective appeal of high-energy food pictures and reduced ad libitum energy intake, without changes in plasma PYY, GLP-1, glucose, or insulin.
Byrne CS, Chambers ES, Alhabeeb H, et al. Am J Clin Nutr, 2016. PMID 27169834
2016 / Randomized, double-blind crossover trial
Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.
van der Beek CM, Canfora EE, Lenaerts K, et al. Clin Sci (Lond), 2016. PMID 27439969
2016 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial evaluated 8 weeks of Ficus carica paste versus placebo in 80 Korean participants with functional constipation. Supplementation significantly decreased colon transit time compared with placebo. Fig paste also significantly improved stool consistency and abdominal discomfort, while organ toxicity markers and blood parameters remained within normal ranges.
Baek HI, Ha KC, Kim HM, et al. Asia Pac J Clin Nutr, 2016. PMID 27440682
2016 / Randomized controlled crossover study and in vitro fermentations
Researchers developed inulin short-chain fatty acid esters to deliver propionate directly to the colon and tested them in vitro and in humans. In a randomized controlled crossover study, participants received 10 g/day of IPE-27, IPE-54, or inulin control for 7 days. In vivo, IPE-27 produced greater 13C recovery in breath CO2 than IPE-54 (64.9 vs. 24.9%, P = 0.001) and reduced energy intake during an ad libitum test meal compared with inulin (439.5 vs. 703.9 kcal, P = 0.025) and IPE-54 (439.5 vs. 659.3 kcal, P = 0.025). Intake with IPE-54 did not differ significantly from inulin control.
Polyviou T, MacDougall K, Chambers ES, et al. Aliment Pharmacol Ther, 2016. PMID 27464984
2016 / Randomized, double-blind, placebo-controlled pilot study
Fifty-six patients with active mild to moderate ulcerative colitis were randomized to receive either 500 mg/day resveratrol capsules or placebo for 6 weeks. In the resveratrol group, serum SOD increased from 122.28 ± 11.55 to 125.77 ± 10.97, TAC increased from 9.87 ± 1.51 to 11.97 ± 1.61, and serum MDA decreased from 5.62 ± 1.18 to 3.42 ± 1.01 (p < 0.001). In addition, resveratrol supplementation significantly decreased disease activity and improved quality of life compared to baseline (p < 0.001).
Samsamikor M, Daryani NE, Asl PR, et al. Arch Med Res, 2016. PMID 27664491
2016 / Randomized controlled trial
Twenty-nine colorectal cancer survivors completed a randomized controlled trial receiving foods with cooked navy bean powder (35 g/day), heat-stabilized rice bran (30 g/day), or no added ingredient. The consumed amounts represented 4-9% of daily caloric intake, with no major gastrointestinal issues reported. Dietary fiber significantly increased in both the navy bean and rice bran groups at Weeks 2 and 4 compared with baseline and control (P <= 0.01). Telomere length correlated with age and HDL cholesterol at baseline, and with improved serum amyloid A levels at Week 4 (P <= 0.05).
Borresen EC, Brown DG, Harbison G, et al. Nutr Cancer, 2016. PMID 27689688
2016 / Animal experiments and 3-month human intervention trial
This study evaluated green-plant thylakoids on gastrointestinal passage in rats and on gut microbiota and fecal fat in 34 healthy human volunteers receiving thylakoid or placebo treatments for three months. In rats, thylakoids reduced gastric emptying and intestinal transit acutely, with non-significant reductions after two weeks. In the human trial, thylakoids increased total bacteria and specifically the Bacteroides fragilis group compared to placebo, while failing to cause steatorrhea.
Stenblom EL, Weström B, Linninge C, et al. Nutr Metab (Lond), 2016. PMID 27777602
2015 / Randomized controlled trial
A 4-week randomized, double-blind, placebo-controlled trial assessed the effects of gluten and milk on gut permeability and behavior in children with autism spectrum disorders. Intestinal permeability was evaluated using the lactulose:mannitol ratio, alongside standardized behavioral scores and gastrointestinal symptoms. Neither intestinal permeability nor behavioral metrics differed between groups receiving gluten and dairy versus placebo, and observed variations were small and not clinically meaningful.
Navarro F, Pearson DA, Fatheree N, et al. Nutr Neurosci, 2015. PMID 24564346
2015 / Randomized controlled trial
A randomized controlled trial compared routine burping to non-burping in 71 mother-infant pairs followed for 3 months. Colic episodes did not decrease significantly in burped infants compared with controls (adjusted RR 0.64; 95% CI, 0.22-1.86, p = 0.41; difference 1.57 episodes/infant/100 weeks [95% CI, -0.63 to 3.76]). Conversely, burping significantly increased regurgitation (adjusted RR 2.05; 95% CI, 1.92-2.18, p < 0.0001; difference 4.36 episodes/infant/week [95% CI, 4.04-4.69]).
Kaur R, Bharti B, Saini SK Child Care Health Dev, 2015. PMID 24910161
2015 / Randomized, single-blind, crossover trial
Thirteen healthy participants received 90-minute ileal infusions of saline control, safflower oil (51.7 kcal), low-dose casein (17.2 kcal), high-dose casein (51.7 kcal), low-dose sucrose (17.2 kcal), or high-dose sucrose (51.7 kcal) via a naso-ileal catheter. Infusion of high-dose lipid, protein, and carbohydrate significantly reduced ad libitum food intake versus control (safflower oil: 464.3±90.7 kcal, P<0.001; high-dose casein: 458.0±78.6 kcal, P<0.005; high-dose sucrose: 399.0±57.0 kcal, P<0.0001 vs control: 586.7±70.2 kcal), an effect that persisted after adding infused calories. Secretion of cholecystokinin and peptide YY increased, while glucagon-like peptide-1 (7-36) did not; delays in gastric emptying and intestinal transit were observed across all macronutrients but were not statistically significant versus control.
van Avesaat M, Troost FJ, Ripken D, et al. Int J Obes (Lond), 2015. PMID 24957485
2015 / In vitro study, acute randomized crossover trial, and 24-week RCT
Researchers tested the effects of an inulin-propionate ester using in vitro human colonic cells, an acute randomized controlled crossover trial, and a 24-week randomized controlled study in 60 overweight adults. Acute ingestion of 10 g inulin-propionate ester significantly increased postprandial plasma PYY and GLP-1 and reduced energy intake. Over 24 weeks, supplementation with 10 g/day significantly reduced weight gain, intra-abdominal adipose tissue distribution, and intrahepatocellular lipid content, while preventing the deterioration in insulin sensitivity observed with the inulin control.
Chambers ES, Viardot A, Psichas A, et al. Gut, 2015. PMID 25500202
2015 / Randomized controlled trial
Hospitalized children with gastroenteritis received rice-based oral rehydration solution with or without 3 mg zinc for 5 days. Both the zinc and control groups showed improvements in sucrose breath tests from baseline to day 5 (P < .05). Intestinal permeability measured by lactulose/rhamnose ratio significantly improved only in the zinc-fortified group (53.0 to 17.7, P < .05), though short-term recovery was not enhanced.
Tran CD, Hawkes J, Graham RD, et al. Clin Pediatr (Phila), 2015. PMID 25520366
2015 / In vivo human volunteer challenge and in vitro study
Researchers conducted human in vivo and in vitro studies to evaluate the gastrointestinal absorption of titanium dioxide nanoparticles compared with larger particles. Human volunteer studies showed that very little titanium dioxide is absorbed gastrointestinally following an oral challenge, with no demonstrable difference in absorption across the three particle sizes tested. In vitro tests showed that all formulations agglomerated in simulated gastric fluid and when dispersed in polymeric or elemental foods, with virtually no translocation across the cell layer. The study found no evidence that nanoparticulate titanium dioxide is more likely to be absorbed in the gut than micron-sized particles.
Jones K, Morton J, Smith I, et al. Toxicol Lett, 2015. PMID 25597860
2015 / Randomized crossover trial
In a crossover trial of 28 healthy female volunteers, 500 mg ascorbic acid alone augmented 6-hour lactulose excretion more than 600 mg aspirin alone compared to placebo. Administering both together produced an additive increase in lactulose excretion. In an additional test of 19 women, the timing of ascorbic acid administration before or after aspirin had no significant effect on sugar excretion.
Sequeira IR, Kruger MC, Hurst RD, et al. Basic Clin Pharmacol Toxicol, 2015. PMID 25641731
2015 / Randomized, double-blind, crossover trial
A randomized, double-blind crossover trial evaluated 4.375 g/day gluten versus rice starch placebo for one week in 61 adults without celiac disease or wheat allergy. In 59 completing participants, gluten significantly increased overall symptoms compared with placebo (P = .034). Gluten provoked significantly more severe abdominal bloating (P = .040), abdominal pain (P = .047), foggy mind (P = .019), depression (P = .020), and aphthous stomatitis (P = .025).
Di Sabatino A, Volta U, Salvatore C, et al. Clin Gastroenterol Hepatol, 2015. PMID 25701700